
Overview
GMP Recombinant Human IL-2 joins IL-7 and IL-15 produced within Bio-Techne’s dedicated animal-free GMP facility located in St. Paul MN USA. Our GMP-grade IL-2 contains the same cysteine to serine mutation found in Proleukin®. This mutation has been reported to prevent cysteine mispairing in E.coli, which can lead to protein aggregation and makes our new GMP-grade IL-2 protein soluble in injectable-grade water.
What this paper found
Moving from research-grade to animal-free GMP-grade recombinant human IL-2 left T cell growth, viability and memory phenotype essentially unchanged. In the supporting comparison, peripheral blood mononuclear cells from three donors were processed on a Fresenius Kabi Lovo automated cell processing system, CD4+ and CD8+ T cells were positively selected, and each grade of IL-2 was tested at 200 IU/mL in a Wilson Wolf G-Rex® 6M well plate for three days, followed by 10 to 11 further days with fresh medium and IL-2. Fold expansion, viability, CD62L and CCR7 positivity and the split between Tscm/Tcm and Teff/Tem subsets were comparable across grades. The GMP protein carries the same cysteine to serine substitution found in Proleukin.
Study details
- Cell type(s)
- T-Cells
How G-Rex® was used
PBMCs from three donors were isolated on a Fresenius Kabi Lovo automated cell processing system, followed by positive selection of CD4+ and CD8+ T cells. The selected T cells were expanded in a Wilson Wolf G-Rex® 6M well plate supplemented with 200 IU/mL IL-2 for three days, then cultured for a further 10 to 11 days with fresh medium and IL-2. The expanded cultures grown in the G-Rex® 6M well plate were analysed for cell expansion, viability and memory phenotype, comparing research-grade, animal-free and GMP-grade IL-2.
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.